3 reports

The Phase II trial is expected to enroll up to ## de novo AML patients ≥ ## years of age, randomized in ##:## ratio to either Filgrastim alone or CLT- ## single infusion plus Filgrastim.

  • Chemotherapy
  • Filgrastim
  • United States
  • World
  • Product Initiative

The Phase II trial is expected to enroll up to ## de novo AML patients ≥ ## years of age, randomized in ##:## ratio to either Filgrastim alone or CLT- ## single infusion plus Filgrastim.

  • Chemotherapy
  • Filgrastim
  • United States
  • World
  • Product Initiative

The Phase II trial is expected to enroll up to ## de novo AML patients ≥ ## years of age, randomized in ##:## ratio to either Filgrastim alone or CLT- ## single infusion plus Filgrastim.

  • Filgrastim
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative